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Expression in mammalian cells of the Escherichia coli 06
alkylguanine-DNA-alkyltransferase gene ogt reduces the toxicity of
alkylnitrosoureas
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Summary V79 Chinese hamster cells expressing either the 06-alkylguanine-DNA-alkyltransferase (ATase)
encoded by the E. coli ogt gene or a truncated version of the E. coli ada gene have been exposed to various
alkylnitrosoureas to investigate the contribution of ATase repairable lesions to the toxicity of these com-
pounds. Both ATases are able to repair 06-alkylguanine (06-AlkG) and 04-alkylthymine (04-AlkT) but the ogt
ATase is more efficient in the repair of 04-methylthymine (04-MeT) and higher alkyl derivatives of 06-AlkG
than is the ada ATase. Expression of the ogt ATase provided greater protection against the toxic effects of the
alkylating agents then the ada ATase particularly with N-ethyl-N-nitrosourea (ENU) and N-butyl-N-
nitrosourea (BNU) to which the ada ATase expressing cells were as sensitive as parent vector transfected cells.
Although ogt was expressed at slightly higher levels than the truncated ada in the transfected cells, this could
not account for the differential protection observed. For-N-methyl-N-nitrosourea (MNU) the increased
protection in ogt-transfected cells is consistent with 04-MeT acting as a toxic lesion. For the longer chain
alkylating agents and chloroethylating agents, the protection afforded by the ogt protein may be a consequence
of the more efficient repair of 06-AlkG, 04-AlkT or both of these lesions in comparison with the ada-encoded
ATase.
Alkylation of DNA is thought to be the mechanism by which
alkylnitrosoureas and related alkylating agents exert their
biological effects. In particular, the presence of 06-AlkG has
been correlated with the toxicity, mutagenicity, clastogenicity
and carcinogenicity of these agents (reviewed by Margison &
O'Connor 1990; Barbin & Bartsch, 1989). The cytotoxicity of
chloroethylating agents appears predominantly to be due to
DNA crosslinking (Erickson et al., 1978) whilst the
mutagenic effects of simple alkylating agents are probably
mediated by 06-AlkG (Abbott & SafThill, 1979) and 04-AlkT
(Duran & Wani, 1987) miscoding during DNA replication.
The mechanisms by which other biological effects are
mediated, such as sister chromatid exchange is not clear. The
carcinogenic potency of a variety of alkylating agents has
been correlated with the formation, persistence or accumula-
tion of 06-AlkG in DNA (Margison & O'Connor, 1990).
However, there are examples where no such relationship
exists (Rogers & Pegg, 1977; Silinskas et al., 1985) and it is
becoming increasingly evident that the formation and repair
of all adducts having a mutagenic potential should be con-
sidered in order to evaluate their contribution to the
biological consequences of alkylating agent exposure.
Prokaryotes have a specific repair mechanism for 06-AlkG
and 04-AlkT which involves the transfer of the alkyl group
to a cysteine residue within an ATase protein in an autoinac-
tivating process (Olsson & Lindahl, 1980; Margison et al.,
1985; Potter et al., 1987). E.coli has two genes which encode
ATase enzymes; ada (Sedgwick, 1983; Margison et al., 1985)
and ogt (Potter et al., 1987). The ada gene encodes a 39 kDa
protein which is composed of two subfragments sized 18 and
20 kDa capable of repairing 06-AlkG, 04-AlkT and the S
stereoisomer of alkylphosphotriesters (AlkPT), respectively.
The ogt gene encodes a 19 kDa protein with a repair function
similar to that of the 18 kDa subfragment of the ada ATase.
Kinetic experiments using synthetic oligonucleotides contain-
ing modified bases have shown that the rates of repair of
06-MeG by the two ATases are almost identical (Wilkinson
et al., 1989). However, the ogt ATase is able to repair
06-ethylguanine 173 times faster and 04-methylthymine 84
times faster than the ada ATase (Wilkinson et al., 1989).
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Cultured mammalian cells expressing low levels of
endogenous ATase activity are ideal model systems for exp-
loring the biological effects of06-AlkG and 04-AlkT in DNA.
Thus vectors containing the entire protein coding region or
truncated versions of the ada gene encoding the 06-AlkG/04-
AlkT ATase have been transfected and expressed in a variety
of cell lines which have then been used to examine the
contribution of these lesions to the toxic, mutagenic and
cytogenetic effects of alkylating agents (reviewed by Mar-
gison & O'Connor, 1990). Since the same subunit of the ada
ATase repairs both 06-AlkG and O4-AlkT, it has not been
possible to assess the relative importance of each of these
adducts. However, as the ogt ATase repairs 04-MeT and
longer alkyl chain derivaties of06-AlkG more efficiently than
the ada ATase, a comparison of mammalian cell lines expres-
sing each of these enzymes provides an approach to establish
the relative biological importance of these lesions.
Materials and methods
Plasmids
A 650 bp EcoRI fragment containing the ogt gene in pUC8
was provided by Dr P.M. Potter (of this Institute) and the
vector pZipneoSV(X)l (Cepko et al., 1984) by Dr. R. Mul-
ligan (Massachusetts Institute of Technology, USA).
Recombinant DNA techniques
All recombinant DNA manipulations such as routine subc-
loning employed standard procedures (Maniatis et al., 1982).
Site directedmutagenesis
Site directed mutagenesis was achieved using the Bio Rad
Mutagene in vitro mutagenesis kit (Kunkel et al., 1987).
Briefly, single stranded M13 DNA containing the ogt gene
was isolated from E. coti CJ236 (a strain deficient in
dUTPase and uracil glycosylase which therefore allows uracil
incorporation in the DNA). A mutagenic oligonucleotide was
annealed and the second strand synthesised in vitro by the
addition ofdTTP, dATP, dCTP, dGTP and Klenow enzyme.
Following transformation of this double stranded DNA into
a wild type E. coli strain, the uracil containing strand was
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digested and the remaining mutant strand was replicated.
Oligonucleotides were synthesised on a DuPont 3000 Coder
using standard phosphoramidite chemistry and purified by
urea polyacrylamide gel electrophoresis.
Mammalian cell culture and MTTsurvival assay
The V79 Chinese hamster lung fibroblasts were maintained in
modified Eagle's medium (MEM) containing 10% foetal calf
serum at 37°C in a humidified atmosphere of 5% C02/95%
air. Transfection of plasmid DNA employed Lipofectin
(Gibco-BRL, Paisley, Scotland) under conditions described
by the manufacturers. Cells were selected and maintained
in medium containing 1.5 mgml' G418 (Gibco-BRL). The
MTT survival assay was based on the method of Carmichael
et al. (1987). Cells (100/well) were plated into a 96 well plate
(Costar) and following a three hour attachment period, vary-
ing concentrations of alkylating agents were added. After 5
days, 50 tl of a 3 mgml-' solution of 3' (4,5,-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT) in phosphate-buffered saline (PBS) was added to each
well and incubated for 3 h. The media was removed and the
formazan crystals formed in the viable cells were solubilised
by the addition of 200y1 of dimethylsulphoxide (DMSO).
The absorbance at 540 nm and 690 nm were determined
using a Titertek Multiscan ELISA plate reader and surviving
fractions were calculated as a percentage of the A690-A540 of
untreated wells. Standard deviations were determined from
values obtained from triplicate wells: the results of one
representative experiment for each agent are presented.
Alkylating agents
Alkylating agents were dissolved at the specified concentra-
tions in the solvents indicated: MNU 5 mgml1' in 1 mM
HCI, ENU 25 mg ml-' in methanol containing 10gM HCI,
BNU 100 mg ml1 in ethanol containing 101M HCI, 1,3-
Bis(2-chloroethyl)-l-nitrosourea (BCNU) and mitozolomide
100 mgmll in DMSO and chlorozotocin 5 mgmll in
DMSO. All solutions were stored at -20°C.
Preparation ofcell extracts
Cells were rinsed with PBS, harvested by scraping and
resuspended at I07 cells ml1' in 50 mM Tris-HCI, pH 8.3,
1 mM EDTA, 3 mM dithiothreitol. Following disruption by
sonication on ice for two periods of 10 s each at 12gm peak
to peak distance, phenylmethylsulphonyl fluoride in ethanol
was added to a final concentration of 0.5 mM and cellular
debris was removed by centrifugation (10,000g for Omin at
4°C). Supernatants were used for protein estimation (Bio
Rad) and for ATase assay.
Alkyltransferase assay
This assay has previously been described (Margison et al.,
1985). Briefly, cell extracts were incubated with calf-thymus
DNA that had been methylated in vitro by reaction with
[3H]MNU. Following incubation with the substrate DNA for
2 h at 37°C, the DNA was hydrolysed to acid solubility in
1 M perchloric acid at 75C for 40 min and labelled proteins
were recovered by centrifugation and quantitated by liquid
scintillation counting. The amount of protein in the cell
extracts was determined and the ATase specific activity was
calculated as fmolemg-' of total protein. The results shown
are the means for at least three different amounts of protein
which could be plotted as a straight line with standard
deviations less than 10%.
Fluorography
Following incubation with [3H]-methylated substrate DNA,
[3H]-labelled proteins were subjected to SDS-polyacrylamide
gel electrophoresis and electroblotted to nitrocellulose. The
membrane was air dried, wetted with Optiphase Highsafe II
scintillation cocktail and exposed to X-ray film at - 80°C for
2 weeks. This is based on the method originally described by
Margison et al. (1985).
Results and discussion
Ligation ofthe ogtprotein coding sequence into
pZipneoSV(X)1
Site directed mutagenesis of the ogt gene was carried out in
order to create an NdeI restriction endonuclease recognition
site 5' to the ogt translation initiation codon. Following
digestion with NdeI, a BamHI-NdeI linker containing the
consensus sequence for eukaryotic translation initiation
|< 0.25kb > [ < 0.4kb >
Ndel H Rl B
TATGCTGAGATTA...
jjACGACTCTAAT
GATCCACCATGGC:: ogt
GTG.TACCGAT
+1.2 kb 0.7 kbq pZipneoSV(X)l
Rl H B H Rl
I F-A MMuLTR neo V400ri pBRO MMuLTR
I 5.8 kb | 4.4 kb l
Figure 1 Construction of pZipogtKL involving insertion of the ogt protein coding region into pZipneoSV(X)l following ligation
of a double stranded oligonucleotide (linker) containing the eukaryotic translation initiation consensus sequence (Kosak, 1987).
Regions of pZipneoSV(X)l shown are: MMuLTR, Moloney Murine Leukemia Virus 5' and 3' long terminal repeats; neo,
neomycin (G418) resistance gene; SV40 On, SV40 Origin of replication; pBRO, pBR322 origin of replication. Translation initiation
codons are underlined. B, BamHI site, H, HindlII site, RI, EcoRI.
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(Kosak, 1987) was ligated 5' to the coding sequence (Figure
1). Subsequent insertion into the mammalian cell expression
vector pZipneoSV(X)l (Cepko et al., 1984) created pZipog-
tKL. These vectors are selectable in mammalian cells since
they contain the neo gene encoding aminoglycoside phos-
photransferase which confers resistance to G418. The neo
gene and the inserted ogt gene were expressed under the
control of Moloney Murine Leukemia Virus (MoMuLV)
LTR promoter and polyadenylation signals. The resulting
ATase was a fusion protein containing two additional amino
acids at the amino terminal end.
Transfection ofChinese hamster V79 cells and isolation of
clones expressing the ogt gene
The plasmid pZipogtKL was transfected into Chinese hams-
ter V79 lung fibroblasts which express very low levels of
endogenous ATase (2-4 fmole mg-'). The parent plasmid,
pZipneoSV(X)l was used in parallel to generate G418 resis-
tant control cells. Ten G418 resistant clones were isolated,
expanded and assayed for their ATase activity (Table I).
Various levels of ATase were detected in the pZipogtKL
transfected cells one clone; LH2, expressed 300 fmole mg-' of
total protein and was used in survival experiments. For
comparison we used the previously described clone SB
(Brennand & Margison, 1986a) which had been transfected
with a truncated form of the ada gene and expressed a
similar level (300fmolemg'1) of the ada 06-AlkG ATase.
This level of ATase is biologically relevant since human
tissues have been shown to contain between 140 and
460fmmg-' of ATase enzyme (Myrnes et al., 1984). The
pZipneoSV(X)l-transfected G418 resistant clone 6E was used
as the negative control cell line.
Analysis ofE. coli ATase expressing clones
Southern analysis of DNA isolated from three pZipogtKL-
transfected ogt ATase expressing clones (Figure 2) and clone
SB (data previously published by Brennand & Margison,
1986a) confirmed that the respective gene sequences has been
incorporated into the cellular DNA. The [32P]-labelled ogt
probe (650 bp) hybridised to DNA fragments of the expected
sizes following digestion with BamHI, and or HindlII of
DNA extracted from clones LH2 and LH7 indicating that
there had been no detectable rearrangement of vector
sequences essential for expression (Figure 1). The expected
650 bp fragment of LH8 DNA hybridised to the ogt probe
following BamHI digestion although a band, larger than
expected was evident upon HindlII digestion. The vector may
have lost a HindlII site and thus the fragment would have
RJKO LH2
B B H R1
been generated by digestion of a site in the genomic DNA.
The reduced size of EcoRI fragments produced may be
explained similarly. Other clones (Table I) were not analysed.
To demonstrate that the ATase activities in extracts of
LH2 and SB were not due to an increase in endogenous
ATase gene expression, the molecular weight of the ATase
protein was determined by SDS-PAGE and fluorography.
Figure 3 shows that LH2 cell extract contains a single
19 kDa ATase which is the correct size of the ogt proten. SB
cell extract contains four [3H]-labelled fusion proteins, the
most abundant of which had the expected molecular weight
of about 25 kDa (Brennand & Margison, 1986a). The addi-
tional bands may have been generated by either functionally
active ATase fragments expressed from additional ATG
codons in frame with the alkyl-acceptor cysteins residue or
by proteolytic cleavage of the 25 kDa ada 06-AlkG ATase.
Multiple protein bands following fluorographic analysis have
been previously identified when the truncated ada gene was
overexpressed in E. coli (Potter et al., 1987). The endogenous
Chinese hamster ATase protein is also about 25 kDa
(Morten et al., 1992) but the expression in clone SB was
unlikely to have been upregulation of the hamster ATase
gene since no G418 resistant clones produced from the trans-
fection of the pZipneoSV(X)l parent plasmid had elevated
levels of ATase activity. Furthermore, the only situation in
which the endogenous hamster ATase has been seen by
fluorography was in extracts ofcells in which upregulation of
ATase had occurred following selection with increasing doses
of the chloroethylating agent, mitozolomide (Morten et al.,
1992).
There was no statistically significant difference (one-way
analysis of variance test) between either the growth rates or
Table I Alkyltransferase activity in extracts of pZipogtKL-
transfected G418 resistant RJKO clones as measured by the method
described in Margison et al. (1985).
RJKO Clone ATase activitya
LHI 85
LH2 300
LH3 2
LH4 2
LH5 50
LH6 85
LH7 115
LH8 130
LH9 2
LH1O 70
SBb 300
afmoles mg
1986a.
-' total protein. bPublished by Brennand and Margison,
LH7 LH8
B H R1 B H Rl
23.1
9.4
6.6
4.4
2.3 -
2.0 -
1.3 -
1.1 -
0.9 -
0.6 -
kb
Figure 2 Southern analysis of DNA from parent RJKO cells and clones LH2, LH7 and LH8 which were transfected with and
express the ogt ATase. Restriction enzymes used were B, BamHI; H, HindIII; RI, EcoRI. The positions of the size markers are
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43.0 -
25.7 -
18.4 -
14.3 -
6.2 -
3.0 -
kDa
Figure 3 Visualisation of ATase proteins by SDS PAGE and fluorography. Lane 1, pure ogt ATase protein; 2,['4C]-labelled
molecular weight markers; 3, LH2 cell extract; 4, SB cell extract. Extracts were incubated with [3H]-methylated substrate DNA and
the [3H]-labelled proteins were resolved by electrophoresis; electroblotted to nitrocellulose and visualised by the addition of a
scintillation cocktail prior to exposure to autoradiographic film.
the fraction of the cells in the GI, S or G2/M phases of the
cell cycle of the three clones LH2, SB and 6E (data not
shown). This is important since certain stages of the cell cycle
may be more susceptable to damage by alkylating agents
(Madox-Jones & Mauro, 1975) and because cells with
different growth rates vary in their sensitivities to cytotoxic
effects (Wilkinson & Nias, 1971). It can therefore be conc-
luded that any differences in resistance to the toxicity of the
alkylnitrosoureas displayed by the clones can not be att-
ributed to differential growth rates or cell cycle parameters.
Functional activity ofthe ogt ATase in mammalian cells
To determine the ability of the ogt enzyme to act on alkyla-
tion damage in LH2 cell DNA, ATase depletion experiments
were performed. Exponentially growing cells (105) were
treated with increasing doses of MNU, ENU, or BNU in
PBS for 1 h at 37°C and extracts were prepared and assayed
for ATase activity. Complete ATase depletion was evident
following 1 h treatment with 40fgml-' MNU and 50%
depletion with 1Ojigml-' (Figure 4a). In contrast, total
depletion ofATase activity could not be achieved using ENU
or BNU: maximal depletion in cells treated was only 55%
with ENU and 40% with BNU (Figure 4a). The possibility
that longer time periods were necessary for the ogt ATase to
act on damage in ethylated and butylated DNA was assessed
by exposing LH2 cells to 100 gml-' BNU for 1 h and
assaying the ATase activity at time intervals up to 19 h later.
The maximum depletion was only 50% and this was after 5 h
(Figure 4b) suggesting that the level of adducts present was
inadequate to completely deplete the ATase. Activity had
returned to 70% of its original value by 19 h after treatment
but the extent to which this incomplete recovery is a conse-
quence of; (1) the slow resynthesis of ATase; (2) the continu-
ing slow rate of action of the ATase on substrate lesions; (3)
inhibition of protein synthesis by BNU; or (4) the repair of
the adducts by non-ATase mechanisms remains to be estab-
lished.
The dose dependent ATase depletion in LH2 cells is an
indication that the bacterial ogt ATase produced by these
cells is capable of acting on alkylation damage in mammalian
DNA. Similarly, the ada ATase has previously been shown to
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Figure 4 Depletion of ATase activity in LH2 cells treated with
a, various doses of MNU (triangles), ENU (squares) or BNU
(circles) or b, with BNU for the times indicated.
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repair 06-MeG in mammalian cell DNA by measuring the
removal of [3H]-O6MeG from DNA following exposure to
[3H]-MNU (Brennand & Margison, 1986b) consistent with
the protection of the cells against the toxic and other effects
of such alkylating agents.
Incomplete depletion of the ATase such as observed after
treatment with ENU and BNU (Figure 4a) has also been
observed in 06-AlkG ada expressing TG15SB7 Chinese
hamster cells following incubation with the former agent
(Fox & Margison, 1988). This also indicates a slower rate of
removal from the 06 position ofguanine of the larger lesions
as compared to methyl adducts.
Effects ofbacterial ATases on cell survival
The survival of LH2 (ogt expressing), SB (truncated ada
expressing) and 6E (control) cells was determined by MTT
survival assays following exposure to increasing doses of
three monofunctional alkynitrosoureas; MNU, ENU and
BNU and three chloroethylating agents; mitozolomide,
BCNU and chlorozotocin (Figure 5). Statistical analysis of
the results by two-way analysis of variance demonstrated
that survival curves obtained for LH2, SB and 6E were
statistically different (P<0.05) from each other for most of
1.04
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¢ t e e
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the alkylating agents. The exceptions were that clones SB and
6E had similar sensitivities to the toxic effects of ENU and
BNU. The differences in cytotoxicity are unlikely to be
related to the clonality of the cells since there no significant
differences between their growth rates and cell cycles as
discussed above. The D30 values (the dose at which 30% of
the cells survived) together with the initial ATase activities of
the cells used for the survival assay are shown in Table II.
Several other groups have now reported increased resistance
to alkylating agents following overexpression of the ada
(Samson et al., 1986; Kataoka et al., 1986; Ishizaki et al.,
Table II D30 values and initial ATase activities in alkylating agent
treated G418 resistant RJKO clones
Clone LH2 SB 6E
ATasea D30 ATaseb D30 ATase D30
MNU 250 135.0 150 108.5 2 41.9
ENU 250 179.0 150 149.0 2 149.8
BNU 241 215.0 96 200.5 2 182.0
Mzc 207 2.4 127 1.6 2 1.3
BCNU 207 3.0 127 2.6 2 2.1
Czd 300 6.4 162 4.8 2 3.9
afmole mg-' protein. bmgml-. cmitozolomide. dChlorozotocin.
I0-~~. d
0~~~~
2 3
2 4 6
Dose of agent (,ug ml -1)
Figure 5 Survival of RJKO clones as determined by the MTT survival assay. LH2 (circles), SB (squares), and 6E (triangles)
following incubation with a range of doses of: a, MNU, b, ENU, c, BNU, d, Mitozolomide, e, BCNU and f, chlorozotocin.
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1987) and human ATase genes (Hayakawa et al., 1990;
Kaina et al., 1991; Wu et al., 1992) in mammalian cells.
The relative increases in resistance of LH2 and SB cells
compared to 6E (based on the D30 values) were not propor-
tional to ATase expression in the cells for any of the drugs
tested. Previously, expression in these Chinese hamster cells
of the complete ada ATase to a level five fold higher than
that of the truncated ada ATase resulted in identical survival
curves following exposure to MNU (Brennand & Margison,
1986a). Indian muntjac cells expressing varying levels of ada
ATase also displayed similar levels of resistance of MNU
(Musk et al., 1989) and it would thus appear that the mam-
malian cells are unable to exploit the maximum potential of
very high levels of exogenous ATase or that some other
lesion is responsible for killing the cells.
LH2 cells are more resistant to the cytotoxic effects of
MNU than SB cells (Figure 5, Table II). It has been demon-
strated (Figure 4a) that 40jig ml' is the minimum dose at
which the ogt ATase is saturated in LH2 cells. However, the
continued transcription and translation of the ATase results
in minimal cytotoxicity at this dose. Since both ogt and ada
ATases are able to repair 06-MeG at the same rate (Wilkin-
son et al., 1989), whereas the ogt ATase repairs 04-MeT
more efficiently than the ada enzyme (Wilkinson et al., 1989),
the difference between LH2 and SB cell survival may be
attributed to the more efficient repair of 04-MeT by the ogt
enzyme, suggesting that even though 04-MeT constitutes
only 0.7% of the total alkylated bases following MNU
exposure (Saffhill et al., 1985) it could be a toxic lesion.
However, unequivocal determination of04-MeT-induced tox-
icity cannot be established without direct measurement of the
adducts. Because longer carbon chain alkylating agents pro-
duce a higher percentage of their total base DNA damage at
the 04-position of thymine than MNU (e.g. ENU, 1-4.3%
and BNU 0.8%, (Saffhill et al., 1985)), we expected a larger
difference between the LH2 and SB cell lines with these
agents. Indeed, LH2 cells were slightly but significantly more
resistant than SB or 6E to ENU and BNU whilst there was
no difference between the SB and 6E survival curves (Figure
5). The human alkyltransferase has also been shown not to
provide Chinese Hamster cells with any additional protection
against the cytotoxicity of ENU (Wu et al., 1992). As the ogt
encoded ATase repairs longer-chain 06-alkylguanine and
presumably 04-alkylthymine adducts more efficiently than the
ada ATase, it is not possible to assess the relative contribu-
tion of these products to the overall toxicity of the longer
chain alkylating agents. The minimal protection observed in
LH2 cells may indicate that the longer chain alkyl lesions are
less cytotoxic than the equivlent methylated lesions or pos-
sibly that non-ATase repair is able to deal with the damage
more effectively.
The survival data for each of the three chloroethylnitro-
soureas generated curves with different shoulder lengths.
Since the molecular structures of the chloroethylating agents
were different, their rate of uptake by and decomposition in
the cells may vary and these effects could give rise to the
different shapes of the observed survival curves (Figure 5).
All three clones were resistant to low doses of BCNU but the
magnitude of the threshold was increased in cells with an
increased ability to repair the damage i.e. the repair
mechanisms were saturated at a higher dose.
LH2 and SB both exhibited greater resistance to the
chloroethylating agents than to ENU and BNU (Figure 5)
when compared to 6E, suggesting that ATase repairable
lesions (e.g. 06-chlorethylguanine and 06-hydroxyethyl-
guanine (Robins et al., 1983) are more cytotoxic than 06-EtG
or 06-BuG. As 06-chloroethylguanine forms interstrand
crosslinks in the DNA (Kohn, 1977), that are known to be
toxic (Erickson et al., 1978), any repair mechanisms which
can act on crosslink precursors will prevent crosslink forma-
tion and increase the resistance of the cells to chloroethylnit-
rosoureas. The reaction of ATase protein with chlorethyl
crosslink precursors may form a covalent complex with the
DNA (Brent & Remack, 1988; Gonzaga et al., 1990) but the
extent to which 06-chlorethyl adducts form such a complex
in vivo, its toxicity and the mechanism of its repair are
unknown. The greater resistance of LH2 cells to the toxic
effects of the chloroethylnitrosoureas, may be due to the
higher ATase activity of the LH2 cells at the time of
exposure to the drugs (Table II) or due to a greater efficiency
of the ogt than the ada ATase to repair chloroethyl or
hydroxyethyl adducts. However, before any conclusions can
be drawn on the relative toxic effects of 06-chloroethyl-
guanine, 06-hydroxyethylguanine, 04-chloroethylthymine and
04-hydroxyethylthymine it will be necessary to determine
their rates of repair by the ada and ogt ATases.
This work was supported by the Cancer Research Campaign.
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